Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent.
Journal Article (Journal Article)
[Figure: see text].
Full Text
Duke Authors
Cited Authors
- Kirtane, AJ; Stoler, R; Feldman, R; Neumann, F-J; Boutis, L; Tahirkheli, N; Toelg, R; Othman, I; Stein, B; Choi, JW; Windecker, S; Yeh, RW; Dauerman, HL; Price, MJ; Underwood, P; Allocco, D; Meredith, I; Kereiakes, DJ
Published Date
- March 2021
Published In
Volume / Issue
- 14 / 3
Start / End Page
- e010144 -
PubMed ID
- 33641374
Electronic International Standard Serial Number (EISSN)
- 1941-7632
Digital Object Identifier (DOI)
- 10.1161/CIRCINTERVENTIONS.120.010144
Language
- eng
Conference Location
- United States